Mysterious ‘alien-like' sea creature that can devour prey 3 TIMES its size is found on UK beach
STUFF OF NIGHTMARES Mysterious 'alien-like' sea creature that can devour prey 3 TIMES its size is found on UK beach
Click to share on X/Twitter (Opens in new window)
Click to share on Facebook (Opens in new window)
BEACHGOERS are being warned to be on the lookout for a mysterious "alien-like" creature after one was discovered on a UK beach.
"Sea mice" are marine worms with a furry appearance that are unlike anything else in the sea and can grow up to six inches long.
Sign up for Scottish Sun
newsletter
Sign up
1
'Sea mice' are active predators but are often washed ashore
A dog walker found one of the strange critters recently on a beach in Wales.
They are active predators, hunting small crabs and other worms on the seabed – but are often washed ashore.
It comes after beachgoers were urged not to pick up cone snails' shells as their venom can cause instant paralysis or even death.
While they are not typically harmful to humans, "sea mice", which get their scientific name from Aphrodite, the Greek Goddess of Love, have sharp bristles that can cause irritation if they pierce the skin.
Simon Parker recently discovered one of the creatures on a Welsh beach prompting discussion on social media due to its curious appearance.
Compared by many to a fossil and even an "alien", the sighting has left many admitting that they had never seen anything quite like it.
Simon was left flabbergasted after discovering one of the six-inch long creatures at Pensarn Beach, Conwy, and turned to tech to determine exactly what it was.
Uncertain of its identity and intrigued by its green-flashing fringe he used Google Lens to determine it was a sea mouse.
"I found it at the water's edge just after low tide," he told Wales Online.
"Unfortunately it didn't appear to be alive. The sea mouse was approximately five or six inches long with brightly coloured bristles down the sides."
Sea mice are not a rare species but their sightings are infrequent, often being washed ashore during stormy weather or left behind by exceptionally low tides.
Another of them was located in March on Oxwich beach in Swansea.
Mum shares urgent warning for summer beach trips with kids as pal's left in hospital following massive allergic reaction
The Wildlife Trusts say the sea mouse is "unlike anything else in the sea".
Despite its potential to reach 20cm in length and 6cm in width this intriguing find is in fact a type of marine worm.
Although it has a tendency to bury itself head-first in the sand this creature boasts a remarkable set of skills.
Its spines typically have a deep red sheen, serving as a warning to potential predators.
However when exposed to light, they flash blue, green, and gold, giving the worm a dazzling, iridescent appearance.
This phenomenon, known as pseudo-birefringence, is the only known example of "photonic engineering" in nature, says the WT.
The spines process light with nearly 100% efficiency – a necessity in the dimly-lit depths of the sea.
Some researchers believe that this unique ability could lead to the development of new communication technologies.
Beauty and the beast
While this creature is technically a marine worm, it is believed that the name "sea mouse" originated from its resemblance to a bedraggled mouse when washed up on shore.
Its Latin name, Aphrodita aculeata, is equally peculiar. While aculeata translates to "spiny" the genus name Aphrodita refers to the ancient Greek Goddess of Love – allegedly due to the worm's resemblance to female genitalia.
The sea mouse is an active predator that feeds on small crabs and other worms and is capable of consuming prey over three times its own body length. Every now and then they can be seen wriggling across the sand – a sight that invariably unnerves beachgoers.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Scottish Sun
a few seconds ago
- Scottish Sun
Two NHS drugs slows and could REVERSE devastating Alzheimer's, ‘exciting' study finds
Click to share on X/Twitter (Opens in new window) Click to share on Facebook (Opens in new window) TWO NHS drugs could be combined to treat, and even reverse, the most common form of dementia, scientists claim. A pair of cancer drugs have been identified as a powerful duo that may tackle Alzheimer's disease, after scientists sifted through 1,300 approved medicines. Sign up for Scottish Sun newsletter Sign up 1 Alzheimer's was reversed in mice Credit: Alamy The American team used cutting-edge computer tools to match the gene changes seen in Alzheimer's patients with medicines that reverse those effects. They found that two cancer drugs, both already available on the NHS, reduced brain degeneration in mice with the disease, and even brought back their memory. The study, from the University of California, San Francisco (UCSF), first looked at how Alzheimer's alters the activity of individual brain cells. They then searched for existing drugs that trigger the opposite changes, with the aim of rewiring damaged neurons and brain cells called glia. And when they tested the top two candidates, letrozole and irinotecan, in lab mice, the results were impressive. One theory of how Alzheimer's comes about is that sticky proteins - like amyloid-beta - start clumping together in the brain years before symptoms appear. These toxic clumps block communication between brain cells and trigger inflammation, eventually causing the cells to die. Some scientists believe this buildup is the root cause of Alzheimer's, so clearing it could stop the disease in its tracks. When combined, the cancer drugs not only halted brain cell damage but also undid toxic clumps of proteins, restored memory and reversed the disease's genetic footprint. Prof Marina Sirota, senior author, said: 'We're excited that our computational approach led us to a potential combination therapy for Alzheimer's based on existing FDA-approved medications.' Common painkiller used for back pain ups risk of dementia by 29%, scientists warn She added: 'Alzheimer's disease comes with complex changes to the brain, which has made it tough to study and treat — but our tools opened up the possibility of tackling that complexity directly.' The scientists then trawled through the anonymised medical records of 1.4million over-65s and found those already taking the cancer drugs were less likely to develop Alzheimer's. Dr Yaqiao Li, the study's lead author, said: 'Thanks to all these existing data sources, we went from 1,300 drugs, to 86, to 10, to just five. 'In particular, the rich data collected by all the UC health centres pointed us straight to the most promising drugs. It's kind of like a mock clinical trial.' Letrozole is typically used to treat breast cancer, while irinotecan is prescribed for colon and lung cancer. Both are already used in the UK. 'So exciting' Prof Yadong Huang, co-senior author, said: 'Alzheimer's is likely the result of numerous alterations in many genes and proteins that, together, disrupt brain health. 'This makes it very challenging for drug development - which traditionally produces one drug for a single gene or protein that drives disease.' He added: 'It's so exciting to see the validation of the computational data in a widely used Alzheimer's mouse model.' The breakthrough, published in the journal Cell, could fast-track trials in humans. Prof Sirota said: 'If completely independent data sources, such as single-cell expression data and clinical records, guide us to the same pathways and the same drugs and then resolve Alzheimer's in a genetic model then maybe we're onto something.' She added: 'We're hopeful this can be swiftly translated into a real solution for millions of patients with Alzheimer's.' Alzheimer's causes a relentless decline in cognition, learning, and memory. But decades of research have only produced two FDA-approved drugs, neither of which can meaningfully slow the decline. In the UK, no disease-modifying drugs are currently approved or available. Instead, the UK relies on symptom-managing drugs, such as Donepezil and Rivastigmine.
Scottish Sun
2 hours ago
- Scottish Sun
Common sweetener in fizzy drinks and yoghurt ‘can kill off the deadliest cancer'
Click to share on X/Twitter (Opens in new window) Click to share on Facebook (Opens in new window) A COMMON sugar substitute used in fizzy drinks, yoghurts and gum could be used to combat one of the deadliest kinds of cancer. Researchers fermented the zero calorie sweetener and tested it against pancreatic cancer - finding that it killed off malignant cells but didn't harm healthy ones. Sign up for Scottish Sun newsletter Sign up 2 Stevia extract could be used to help fight pancreatic cancer, researchers suggested Credit: Getty 2 They tested fermented extracts against pancreatic cancer cells in a lab dish Credit: Getty Stevia is a shrub-like herb used to sweeten drinks and desserts instead of sugar, which can also be bought as powder or tablets. Previous research has suggested that stevia leaf extracts could have potential "anticancer effects". But isolating specific substances within the herb that could help protect against cancer and using them has remained challenging. Researchers from Hiroshima University suggested fermenting stevia with bacteria can structurally change the extract and produce bioactive metabolites - compounds that can impact living organisms. Study author Masanori Sugiyama, a professor in the Department of Probiotic Science for Preventive Medicine, said fermentation - or "microbial bio-transformation" - could "enhance the pharmacological efficacy of natural plant extracts" like stevia. The team tested their theory out against pancreatic cancer cells. "Pancreatic cancer is a highly malignant tumour of the digestive system with a poor prognosis," co-author Prof Narandalai Danshiitsoodol said. "Globally, the incidence and mortality rates of pancreatic cancer continue to rise, with a five-year survival rate of less than 10 per cent. "The primary reason pancreatic cancer is considered one of the deadliest cancers is its subtle, insidious onset, with most patients being diagnosed at an advanced stage and missing the optimal treatment window. "Furthermore, pancreatic cancer is highly invasive and prone to metastasis, showing significant resistance to existing treatments such as surgery, radiotherapy, and chemotherapy, resulting in very limited therapeutic efficacy. The most common symptoms of pancreatic cancer - as patients share their stories "Therefore, there is an urgent need to identify new and effective anticancer compounds, particularly those derived from medicinal plants." Researchers used lactic acid bacteria to ferment stevia extracts. They isolated over 1200 strains from fruits, vegetables, flowers, and medicinal plants and evaluated their health benefits. They finally landed on Lactobacillus plantarum SN13T strain (FSLE) derived from banana leaves "to enhance the antioxidant and anticancer activities of stevia leaf extract through fermentation". They tested fermented and non-fermented stevia extracts against pancreatic cancer cells in lab dishes. Fermented stevia killed pancreatic cancer cells more efficiently than the non-fermented extract, the study published in the International Journal of Molecular Sciences found. This suggested that "the fermentation process enhances the bioactivity of the [stevia] extract", Prof Sugiyama said. Researchers tested out different fermentation levels to see which was most effective against cancer cells. Symptoms of pancreatic cancer PANCREATIC cancer doesn't always cause symptoms in its early stages. As the cancer grows and you do begin to show signs, these may come and go and be unspecific, making it hard to diagnose, according to Pancreatic Cancer UK. Common symptoms include: Indigestion - a painful, burning feeling in your chest with an unpleasant taste in your mouth Tummy or back pain - it may start as general discomfort or tenderness in the tummy area and spread to the back, which get worse lying down and feel better is you sit forward Diarrhoea and constipation - see a GP if you have runny poos for more than seven days, especially if you've lost weight as well Steatorrhoea - pale, oily poo that's bulky, smells horrible and floats, making it hard to flush Losing a lot of weight without meaning to Jaundice - yellow skin and eyes, as well as dark pee, pale poo and itchy skin Lower concentrations didn't kill cancer cells immediately, but they slowed their growth. Healthy kidney cells were mostly unaffected by the stevia extracts. Researchers plan to study how fermented stevia affects cancer in mice next, to see how various dosages will work in living organisms. 'The present study has substantially enhanced our understanding of the mechanism of action of the Lactobacillus plantarum SN13T strain in the fermentation of herbal extracts, while also offering a valuable research perspective on the potential application of probiotics as natural anti-tumour agents,' Prof Danshiitsoodol said. In the UK, about 10,800 people are diagnosed with pancreatic cancer each year and 9,600 pass away from it, according to Cancer Research UK. It's the fifth most common cause of cancer death. Since the early 1990s, pancreatic cancer incidence rates have increased by 18 per cent in the UK. The disease is often diagnosed at a late stage because it frequently lacks noticeable symptoms in the early stages. Surgery, chemotherapy and radiation can help extend patients' lives. A blood test to pick up early signs of pancreatic cancer is being trialled in patients with a recent diagnosis of type 2 diabetes - a known risk factor for the disease. Meanwhile, researchers at Case Western Reserve University and Cleveland Clinic have developed a new type of jab to fight pancreatic cancer.
South Wales Argus
3 days ago
- South Wales Argus
Wales will become home to new AI Growth Zone, UK Government
Wales has been named as the future home of an AI Growth Zone, part of the UK Government's Plan for Change, which aims to generate economic growth through advanced technology. The zone is expected to attract billions of pounds in investment and create thousands of high-skilled jobs. Peter Kyle, UK secretary of state for science, innovation and technology, said: "From the coalmines of the Valleys to Swansea's mantra of 'Copperopolis', Welsh trailblazers were the beating heart of the industrial revolution. "AI is this generation's next great industrial leap, so who better to help drive that change than a nation which has always been a by-word for innovation. "These Growth Zones will revitalize communities in the here and now – unlocking fresh investment and new opportunities for those that have been left out in the cold for too long." AI Growth Zones are designed to accelerate the development of critical infrastructure such as data centres. These centres will support breakthroughs in areas like healthcare, climate science, and other sectors by enabling the processing of vast amounts of data. The plan is part of a broader government strategy to increase the UK's computing capacity twenty-fold—ensuring the infrastructure is in place to train and deploy advanced AI models. Jo Stevens, secretary of state for Wales, said: "Wales is already home to a thriving and growing tech industry and this investment in at least one AI Growth Zone for Wales is a vote of confidence in the Welsh economy and testament to the skills and potential of our workforce. "This is another significant step forward in our central mission to kickstart economic growth, create well-paid jobs and unlock opportunity in the industries of the future." The zones are expected to attract significant private investment, particularly in areas with strong power connections and potential for clean energy use. Wales has already set a target to meet 100 per cent of its electricity needs from renewable sources within the next decade. Work is already underway to establish Wales as a leader in AI, with US-based Vantage Data Centers planning to build one of Europe's largest data centre campuses in the country.
